These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


336 related items for PubMed ID: 111368

  • 21. Inhibition of the plasminogen activator urokinase by alpha-tocopherol.
    Ogston D.
    Acta Haematol; 1982; 67(2):114-8. PubMed ID: 6801892
    [Abstract] [Full Text] [Related]

  • 22. Human hepatoma cell line plasminogen activator.
    Levin EG, Fair DS, Loskutoff DJ.
    J Lab Clin Med; 1983 Oct; 102(4):500-8. PubMed ID: 6311924
    [Abstract] [Full Text] [Related]

  • 23. The rapid fibrin plate - a method for plasminogen activator assay.
    Marsh NA, Gaffney PJ.
    Thromb Haemost; 1977 Aug 31; 38(2):545-51. PubMed ID: 579495
    [Abstract] [Full Text] [Related]

  • 24. Kinetics of the inhibition by plasminogen activator inhibitor 2 of urokinase isolated from human urine and recombinant microorganisms. Further evidence for correct tertiary structure of recombinant urokinase.
    Cramer J, Steffens G, Günzler WA, Hess V, Flohé L.
    Arzneimittelforschung; 1988 Aug 31; 38(8):1196-8. PubMed ID: 3143371
    [Abstract] [Full Text] [Related]

  • 25. Absence of synergism between tissue-type plasminogen activator (t-PA), single-chain urokinase-type plasminogen activator (scu-PA) and urokinase on clot lysis in a plasma milieu in vitro.
    Collen D, De Cock F, Demarsin E, Lijnen HR, Stump DC.
    Thromb Haemost; 1986 Aug 20; 56(1):35-9. PubMed ID: 3095946
    [Abstract] [Full Text] [Related]

  • 26. [Index of fibrinolysis with new fibrin plate (author's transl)].
    Hishikawa Y, Sugie I.
    Nihon Seirigaku Zasshi; 1977 Aug 20; 39(1):1-11. PubMed ID: 140239
    [Abstract] [Full Text] [Related]

  • 27. Microplate immunocapture assay for plasminogen activators and their specific inhibitors.
    Stephens R, Leung KC, Pöllänen J, Salonen EM, Vaheri A.
    J Immunol Methods; 1987 Dec 24; 105(2):245-51. PubMed ID: 3121752
    [Abstract] [Full Text] [Related]

  • 28. Detection and partial characterization of a specific plasminogen activator inhibitor in human chondrocyte cultures.
    Yamada H, Stephens RW, Nakagawa T, McNicol D.
    J Biochem; 1988 Dec 24; 104(6):960-7. PubMed ID: 3149640
    [Abstract] [Full Text] [Related]

  • 29. Purification of a plasminogen activator inhibitor indistinguishable from alpha1-antitrypsin and an urokinase inhibitor in pregnancy plasma.
    Clemmensen I, Thorsen S, Müllertz S.
    Haemostasis; 1976 Dec 24; 5(4):218-30. PubMed ID: 826461
    [Abstract] [Full Text] [Related]

  • 30. Fibrinolytic activity of lung and spleen extracts observed in conventional but not in germ-free rats.
    Okamoto U, Yamamoto JI, Nagamatsu Y, Horie N.
    Thromb Haemost; 1979 Aug 31; 42(2):726-33. PubMed ID: 92068
    [Abstract] [Full Text] [Related]

  • 31. [Releasing of plasminogen-activator from the kidney to the blood (author's transl)].
    Nakata A, Hagita M, Okamoto U.
    Nihon Seirigaku Zasshi; 1978 Nov 31; 40(11):419-26. PubMed ID: 155161
    [Abstract] [Full Text] [Related]

  • 32. Endotoxin induction of an inhibitor of plasminogen activator in bovine pulmonary artery endothelial cells.
    Crutchley DJ, Conanan LB.
    J Biol Chem; 1986 Jan 05; 261(1):154-9. PubMed ID: 3079753
    [Abstract] [Full Text] [Related]

  • 33. Amiloride selectively inhibits the urokinase-type plasminogen activator.
    Vassalli JD, Belin D.
    FEBS Lett; 1987 Apr 06; 214(1):187-91. PubMed ID: 3106085
    [Abstract] [Full Text] [Related]

  • 34. [Detection of tumor markers in uterine cancer (plasminogen activators, plasminogen activator inhibitors) using fibrin autography].
    Itoh Y, Nozaki S, Sawaguchi K, Masuda T, Yabushita H, Noguchi M, Miyata N, Nakanishi M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Oct 06; 44(10):1277-8. PubMed ID: 1431441
    [No Abstract] [Full Text] [Related]

  • 35. The plasma inhibitors of plasminogen activator, studied by a zymographic technique.
    Booth NA, Anderson JA, Bennett B.
    Thromb Res; 1985 May 01; 38(3):261-7. PubMed ID: 3161209
    [Abstract] [Full Text] [Related]

  • 36. The influence of the polyphenols of cider on plasmin and plasminogen activators.
    Ogston D, Lea AG, Langhorne P, Wilson SB.
    Br J Haematol; 1985 Aug 01; 60(4):705-13. PubMed ID: 3161536
    [Abstract] [Full Text] [Related]

  • 37. Comparative studies on human activators of plasminogen.
    Mackie M, Booth NA, Bennett B.
    Br J Haematol; 1981 Jan 01; 47(1):77-90. PubMed ID: 6449216
    [Abstract] [Full Text] [Related]

  • 38. Differential inhibition of two molecular forms of melanoma cell plasminogen activator by a placental inhibitor.
    Lecander I, Roblin R, Astedt B.
    Br J Haematol; 1984 Jul 01; 57(3):407-12. PubMed ID: 6430331
    [Abstract] [Full Text] [Related]

  • 39. Immunofluorescence study on thrombolysis with special reference to the patterns of distribution and the contents of fibrin, plasminogen, alpha2-macroglobulin and urokinase in artificial thrombi.
    Hisano S.
    Thromb Haemost; 1978 Feb 28; 39(1):53-60. PubMed ID: 77051
    [Abstract] [Full Text] [Related]

  • 40. Purification of epidermal plasminogen activator inhibitor.
    Hibino T, Izaki S, Izaki M.
    FEBS Lett; 1986 Nov 24; 208(2):273-7. PubMed ID: 3096778
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.